Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 344 participants.
Also called NCT07537933
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 344 participants
- Sponsor
- Registry
-
NCT07537933
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07537933. Randomized; single masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2028-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion
- Acronym
- IA-Tirofiban
- Condition
- Acute Ischemic Stroke
- Condition
- Large-vessel Occlusion
- Condition
- Endovascular Treatment
- Intervention (Drug)
- Tirofiban
- Lead sponsor
- Shandong Provincial Hospital
Record details
- Record id
cardio:ct-nct07537933- Content hash
0a41eef4005e902ee32b9a36e60c51ffb5d637e8616b394391ba920308aa7e87